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Many carriers used in solid dispersions. Fenofibrate causes problems due to their hygroscopic nature. Hence, continuous search for new carriers and new techniques is going on which will be useful for large scale manufacturing. Many polymers have limitations in enhancing the solubility of poorly water-soluble drugs due to their high viscosity. The use of polymers with low viscosity and high swelling capacity offers a better alternative for these types of polymers. The use of natural polymer is more beneficial because of their low cost, biocompatibility, and biodegradability.Locust bean gum (LBG) is a natural polymer which called carob bean gum or carubin and is extracted from the seeds (kernels) of the carob tree Ceratonia siliqua, family Leguminosae or Fabaceae. LBG is used as fat replacer and it can be used as thickening and stabilizing agent. LBG is widely used because of its high swelling capacity, high water retention capacity, easy digestible nature, binding ability, abound availability, and chemical compatibility. The United States Food and Drug Administration approved limit from inactive ingredient database for LBG is 74.25 mg.[11]The present work examines the influence of modified locust bean gum (MLBG) on solubility enhancement of poorly water-soluble drug. Fenofibrate acts through inhibhitor-mediated mechanism. It causes lipolysis and causes decreased production in very low-density lipoprotein level (Bart et al. 1998).In this photo microscopic study, the surface characteristic of pure LBG is viewed by simple compound microscope to analyze surface morphology. Green-colored structures can be seen. The surface characteristics of MLBG are viewed with the help of simple compound microscope, and yellowish features are observed which gives clear indication of conversion of LBG to its modified form MLBG.[12]
INTRODUCTIONResearch for alternative carriers has been increasing to suit for the industrial applications as well as to reduce the production cost and toxic effects. Recently, many natural polymers have been evaluated for their use in new applications. The dissolution rate of drugs from the formulations containing viscous carriers is generally low due to the formation of the gel layer on the hydrated surfaces, which prevents the drug release during dissolution. This can be overcome during tablet formulation by adding disintegrates. Pulverization of the product is a fenofibrate, another important drawback with the high viscosity carriers, which can be overcome using decreasing order of polymer:drug ratio during formulation. However, it is reported that the swelling ability of the carrier improves the dissolution rate of poorly water-soluble drug (Chiou and Riegelman 1969; 1971). As the viscosity of the carrier reduces the dissolution rate, it is useful to modify the gum in such a way that its swelling ability remains the same and viscosity reduced.[1,2] This can be achieved by heating.The rate at which poorly water-soluble drug dissolves is often the slowest step and therefore exerts rate-limiting effect on drug bioavailability.[3-5] In case of drugs with the dissolution rate limited absorption, reduction in particle size (Patel et al., 2008) often increases the rate of dissolution and the amount of drug absorbed. The rate of absorption can be further increased using various techniques which include solid dispersions solvent disposition, cosolvents, salt formation, pH control, and cogrinding. However, all these techniques have potential limitations.[6-8] All poorly water-soluble drugs are not suitable for improving their solubility by salt formation. Decreasing particle size increases solubility, but there are poor wetting and flow. Solid dispersions can overcome these problems.[9,10]
ABSTRACT
Introduction: Modern techniques, such as high-throughput screening or combinatorial chemistry, facilitate the speedy 
identification of new, highly potent chemical entities. Very often new compounds exhibit higher molecular weights and lower water 
solubility compared to drugs already on the market. Fenofibrate is poorly water-soluble (BCS class II) drug. Aim and Objectives: 
The aim of present study was to develop an alternative carrier to reduce the production cost and toxic effects and enhance the 
solubility of fenofibrate. Results: The solid dispersions were prepared using modified locust bean gum using kneading and solvent 
evaporation method that increased in apparent solubility and the dissolution rate of fenofibrate.
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MATERIALS AND METHODSFenofibrate was obtained from USV pharmaceuticals, Baddi, Himachal Pradesh. LBG was obtained from Triveni Chemicals, Vapi, Gujarat, as a gift sample. All other reagents were found to be of analytical grade.
Preparation of MLBGThe MLBG was prepared by the method reported by Babu et al., 2002. Powdered gum was placed in a porcelain bowl and subjected to heating in a hot air oven for different time periods at different temperatures, i.e., 140°C at 2 h. The prepared MLBG was finally resieved (100 mesh) and stored in an airtight container at 25°C.[13,14]
Characterization of LBG/MLBGLBG powder (1 g) was accurately weighed and transferred to a 100-ml stoppered measuring cylinder. Initial volume of the powder in the measuring cylinder was noted. The volume was made up to 100-ml mark with distilled water. The volume occupied by the gum sediment was shaken gently and set aside for 24 h at room temperature and ambient humidity. The volume occupied by the gum sediment was noted after 24 h. Swelling capacity of LBG/MLBG was expressed in terms of swelling index. Swelling index was expressed as a percentage and calculated according to the following equation:SI = [(Xt-X0)/X0] × 100Where X0  is the initial height of the powder in a graduated cylinder and Xt denotes the height occupied by swollen gum after 24 h.
Angle of ReposeThe angle of repose was determined by the funnel method. The accurately weighed powder was taken in a funnel. The height of a funnel was adjusted in such a way that its tip just touches the apex of the heap of powder. The powder was allowed to flow through funnel freely on to the surface.[15] The diameter of the powder heap was measured, and angle of repose was calculated using the following equation:
tan(θ)=H/R
Photo Microscopic StudyPhoto microscopic image of LBG and MLBG was taken at ×100 Magnification (LABINDIA, AMBALA).
CompressibilityCompressibility index (Carr’s index) (Aulton. E. Michael 2007) was determined using the following equation:
( ) ( )' Tapped density-Bulk densityCarr s index % = Tapped density ×100    
Methods of Preparation of Solid DispersionsSolid dispersions were prepared by different methods to enhance the aqueous solubility of FENOFIBRATE using MLBG except in case of modified solvent evaporation (SE) method where both LBG and MLBG were used for the preparation of SD.
Physical Mixture (PM)The PM of fenofibrate and MLBG was prepared by simple blending the FENOFIBRATE and MLBG in 1:1 and 1:5 w/w ratio with a spatula and passed through a 100-mesh sieve.
Kneading MethodIn this method (Choudhary et al., 2009, Gaikwad et al. 2011), the drug and polymer MLBG was taken in different ratios (1:1, 1:2, 1:3, 1:4, and 1:5) in mortar and pestle and triturated properly with 70% v/v methanol until a paste-like consistency is obtained. The paste-like formation is well scrapped out and put in a tray drier at 45°C. It is collected and stored in airtight polybags placed in desiccators.[16,17]
Solvent evaporation MethodIn this method (Sharma et al. 2009), the drug and polymer MLBG was taken in different ratios (1:1, 1:2, 1:3, 1:4, and 1:5) in a 100 ml beaker with 70% v/v methanol. The mixture was stirred on a magnetic stirrer and evaporated at 45°C. Paste-like formation is well scrapped out and dried in a tray drier. It was collected and stored in airtight polybags placed in desiccators.
Characterization of Solid Dispersions
Solubility studyThe solubility of drug was analyzed in various different mediums, i.e., in phosphate buffer ph 6.8, phosphate buffer ph 7.4, distilled water, and 0.1 M sodium lauryl sulfate. Drug was taken in excess (10 mg) in glass vials containing the respective solutions (20 ml). Shaken for 24 h on a rotary shaker. Supernatant liquid was taken and filtered through Whatman filter paper (100 pores) and analyzed under UV at 290.5 nm, and solubility was calculated by respective calibration curve for each medium [Table 2].[18,19]
Phase Solubility StudyPhase solubility study of drug was carried with polymer MLBG. The excess amount of drug was taken in glass vials, and 20 ml of 0.1%, 0.2%, 0.3%, 0.4%, and 0.5% w/v solution of MLBG in phosphate buffer ph 7.4 was added and was shaken for 24 h on rotary shaker at 25 ± 2°C. These solutions were filtered through Whatman filter paper and analyzed under UV at 290.5 nm absorbance. Consecutively, solubility in different phases of polymer is determined [Table 3].[20,21]
In Vitro Dissolution Rate StudyAccurately weighed preparation equivalent to 40 mg of fenofibrate was added to 900 ml of dissolution media 0.1 M Sodium Lauryl Sulfate (FENOFIBRATE) contained in USP dissolution apparatus Type I maintained at 37 ± 0.5°C at 50 rpm. 10 ml aliquots were withdrawn at 5, 10, 15, 30, 45, and 60 and replaced by 10 of fresh dissolution media (37°C). The collected samples were analyzed after suitable dilution (if required) at 290.5 nm using UV spectrophotometer against the blank. The drug release studies were carried out in triplicate (Choudhary et al., 2009). The release profile data were analyzed cumulative percentage drug dissolved at different time intervals, and dissolution efficiency (DE) (Khan and Rhodes 1994, Ronak Patel et al. 2012) was calculated according to Khan et al.[22-25] [Table 4].
Infrared Spectroscopic StudyFourier transformed infrared spectra of fenofibrate, MLBG, PM, and solid dispersions of fenofibrate–MLBG were obtained on a ATR (Bruker alpha, Germany) The scanning range was 600–4000 and the resolution was 1 cm−1.
Scanning Electron MicroscopyThe scanning electron microscope (SEM) photographs of 
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fenofibrate and solid dispersions prepared by modified SE method were obtained by SEM (DIYA LABS, NAVI MUMBAI).
Differential Scanning Calorimetry (DSC)DSC curves of fenofibrate, MLBG, PMs, and solid dispersions (SE method) were obtained by a differential scanning calorimeter (DSC 60 Shimadzu, Japan) at a heating rate of 20°C/min from 50°C–300°C in nitrogen atmosphere.
X-Ray Diffraction (XRD) StudiesPowder XRD patterns of fenofibrate, MLBG, and solid dispersions (SE Method) were recorded using diffractograms (PW 1140, 
Mettler Toledo,) Cu-kα radiation. Diffractograms were run at a scanning speed of 2/mm and a chart speed of 2/2 cm per 2θ.
RESULTSThe results of the characterization of LBG and MLBG are given in Table 1. The results indicated that the viscosity of MLBG was markedly lower when retention capacity of MLBG was not reduced significantly comparing to that of LBG. Due to the swelling nature of the carrier, the extensive surface of the carrier is increased during dissolution, and the dissolution rate of drug is markedly enhanced. Water retention capacity of the carrier is the amount of water retained in it which indicates the ability of carrier toward hydrophilic nature [Table 1]
DISCUSSIONThe above phase solubility of fenofibrate with MLBG shows positive deviation from the normal to Ap type.From the above solubility study analysis, it was determined that, as the concentration of gum increases, the solubility of fenofibrate was enhanced in the increasing manner. The optimization of drug/polymer ratio was done by solubility measurement using different polymer ratios, and subsequently, methods were optimized which gives the best solubility, drug content, and subsequent parameters with enhanced dissolution profile. It was observed that 1:3 ratio significantly increases the solubility of fenofibrate prepared by SE method.
In Vitro Dissolution Rate StudyThe in vitro dissolution profile shows a comparative study of PMs and various solid dispersions made by Kneading method and SE method. The DE is best shown by SDE-3 at DE10 and DE30, i.e. ,32.18% and 46.43%, consequently the % drug release shown by SDE-3 87.56%.It was proved that, as the viscosity of the carrier increased, the dissolution rate was decreased. During the process of dissolution, as soon as the drug carrier particle comes in contact with dissolution fluid, seeping in of dissolution medium into the drug-carrier particle takes place, which initiated the formation of the gel layer of carrier around the particle. The diffusion of dissolved drug through the gelatinous layer is determining factor in the enhancement of dissolution rate. From the Stokes–Einstein equation, the diffusion coefficient is inversely proportional to viscosity. The viscosity of 1% w/v solution of MLBG at 28°C is lower than that of LBG. Thus, the dissolution rate of FENOFIBRATE from the MLBG solid dispersion is higher than that of LBG. During the dissolution process, the drug-carrier particles are to be 
dispersed rapidly throughout the dissolution medium to promote the drug release. It was observed that the LBG which is more viscous than MLBG resulted in the formation of lumps of drug-carrier particles during dissolution, whereas fenofibrate–MLBG particles dispersed rapidly.
Infrared Spectroscopy Study
 FTIR spectrum is shown in Figure 8.
Table 1: Preformulation parameters for MLBG and 
LBG
Characterization 
of API
LBG MLBG
Bulk density 0.55 (g/cm3) 0.49 (g/cm3)
Tapped density 0.75 (g/cm3) 0.65 (g/cm3)
Carr’s index 0.26 0.24
Hausner’s ratio 1.37 1.32
Angle of repose 42.67◦ 40.98◦
Viscosity 1650 cps 561 cps
Swelling index 4.5 3.0
MLBG: Modified locust bean gum, LBG: Locust bean gum
Table 2: Solubility study of drug (Fenofibrate) was 
performed in various solvents
Different media Solubility 
(µg/ml)
Solubility 
(mg/ml)
Phosphate buffer pH 6.8 4.15 0.004
Phosphate buffer pH 7.4 22.28 0.022
Distilled water 12.68 0.012
0.1M SLS 20.26 0.020
Table 3: Phase solubility study of fenofibrate with 
MLBG
Concentration of 
MLBG (%)
Solubility(µg/ml) Solubility(mg/ml)
0.1 4.33 0.043
0.2 9.98 0.009
0.3 18.33 0.018
0.4 26.96 0.026
0.5 36.88 0.036
MLBG: Modified locust bean gum
Table 4: DE of solid dispersions (Khan and 
Rhodes 1994)
Formulation 
code
DE at 
t10 (%)
DE at 
t30 (%)
SDK1 31.90 36.00
SDK2 30.24 42.40
SDK3 39.66 41.73
SDK4 24.67 43.46
SDK5 31.12 44.43
SDE1 31.44 42.40
SDE2 15.44 40.20
SDE3 32.18 46.43
SDE4 12.43 19.19
SDE5 26.37 22.50
DE: Dissolution efficiency
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Scanning Electron MicroscopyThe above Figures 1-8 reveal the SEM pictures of pure drug (fenofibrate), MLBG, and solid dispersions, i.e., respectively, Figures 9-11 SEM figures completely show that fine surfaces of drug have become rough in solid dispersion made in Figure 11, showing drug entrapment.
Differential Scanning CalorimetryThe DSC thermograms of PM, MLBG, PM–MLBG, and solid dispersions (modified SE method) are shown in Figures 12-15. The thermograms of PM exhibited endothermic peak at 80.95, while MLBG exhibited a broad endothermic peak owing to its amorphous nature. The DSC thermograms of PM as well as solid dispersions showed identical peaks corresponding to pure drug, but sharpness of the peaks was decreased.
X-Ray Diffraction StudiesXRD spectra of pure PM, MLBG, and optimized batch of solid dispersions are presented in Figures 16-19. The X-ray diffractogram of PM has sharp peaks at diffraction angles (2θ) 23°, 21°, 22° showing a typical crystalline pattern. However, all major characteristic crystalline peaks appear in the diffractogram of solid dispersions system but of low intensity.
DISCUSSIONThe result of swelling capacity and viscosity studies revealed that the modified forms possessed swelling properties similar to that of LBG, but viscosity was decreased as a function of temperature and exposure time. However, it was observed that LBG samples were charred when heated at 140°C. In the preparation of MLBG, no further change in the viscosity of LBG was observed by heating it at 120°C for 2 h. Hence, these conditions of heating at 120°C for 2 h were selected to prepare MLBG. The prepared MLBG was finally resieved (100 mesh) and stored in an airtight container at 25°C.
Figure 1: Photo microscopic image of locust bean gum
Figure 2: Photo microscopic image of modified locust bean gum
Figure 3: Phase solubility study with modified locust bean gum 
(Graphical Representation)
Figure 4: Phase solubility curve of fenofibrate with modified locust 
bean gum
Figure 5: Solubility of physical mixtures and solid dispersions prepared 
by kneading and solvent evaporation method
Figure 6: In vitro drug release of fenofibrate from solid dispersions 
prepared by Kneading method
Figure 7: In vitro drug release of fenofibrate from solid dispersions 
prepared by SE method
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The dissolution rate of PM from solid dispersions of LBG prepared by modified SE method was low when compared with solid dispersions of MLBG because of high viscosity of LBG. Hence, various SDs were prepared using MLBG than LBG to enhance the solubility of fenofibrate. Improvement in dissolution rate of fenofibrate by PM compared with pure drug might be the solubilization effect and wetting ability of the MLBG on 
Figure 8: Infrared overlay of fenofibrate, modified locust bean gum, and solid dispersion
Figure 9: Pure drug
Figure 10: Modified locust bean gum (polymer)
Figure 11: Solid dispersion
Figure 12: Pure drug
Figure 13: Modified locust bean gum
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fenofibrate. On the basis of the results obtained, the method of preparation of solid dispersions of fenofibrate influences the rate of dissolution of fenofibrate.The reason for higher dissolution rate of SE compared with other solid dispersions may be due to the availability of increased surface area of particles in the suspension. Infrared spectra of fenofibrate and that of solid dispersions showed the same characteristic peaks, indicating no modification or interaction between the drug and the carrier. SEM photographs showed a decrease in crystallinity of fenofibrate. These observations further confirmed by the results of DSC and XRD studies. The DSC thermograms of PM as well as solid dispersions showed identical peaks corresponding to pure drug indicated no well-defined chemical interaction between fenofibrate and MLBG. Further, the decrease in sharpness of fenofibrate endothermic peak in both the solid mixtures may be due to the low amount of the drug in 
the dispersions and decrease in crystallinity of fenofibrate. IR and DSC studies support the same hypothesis, which is confirmed by X-ray diffractometry. XRD spectra of fenofibrate showed sharp peak at different diffraction angles (2θ). All major characteristic crystalline peaks appear in the diffractogram of solid dispersions system but of low intensity. This proves a decrease in crystallinity of fenofibrate as some of the drug gets converted to amorphous form in solid dispersions.
CONCLUSIONOur studies showed that MLBG could be used as a potential carrier in the dissolution rate enhancement of fenofibrate. The dissolution rate of fenofibrate from solid dispersions of MLBG prepared by SE method was high when compared with solid dispersions prepared by Kneading method because of proper drug entrapment in SE method, and dissolution is enhanced because of low viscosity of MLBG. Hence, various SDs were prepared using MLBG. Increase in apparent solubility of fenofibrate from solid dispersions increases the dissolution rate of fenofibrate. Increased 
Figure 14: Physical mixture
Figure 15: Solid dispersion
Figure 16: Pure drug
Figure 17: Modified locust bean gum
Figure 18: Physical mixture
Figure 19: Solid dispersion
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wettability, dispersibility, and solubilization effect of MLBG enhance the solubility of fenofibrate. The results demonstrated that the optimum fenofibrate:MLBG ratio is 1:3. Among all the methods used in the preparation of solid dispersions, modified SE method gave higher dissolution rate.
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